Systemic gabapentin and S(+)-3-isobutyl-γ-aminobutyric acid block secondary hyperalgesia
Gabapentin (GBP) and S(+)-3-isobutyl-γ-aminobutyric acid (IBG) are anticonvulsant agents which are effective against many clinical and experimental neuropathic pain states. We examined the efficacy of these agents in a new rat model of secondary mechanical hyperalgesia generated by a mild thermal in...
Gespeichert in:
Veröffentlicht in: | Brain research 1998-11, Vol.810 (1), p.93-99 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 99 |
---|---|
container_issue | 1 |
container_start_page | 93 |
container_title | Brain research |
container_volume | 810 |
creator | Jones, Denise L. Sorkin, Linda S. |
description | Gabapentin (GBP) and
S(+)-3-isobutyl-γ-aminobutyric acid (IBG) are anticonvulsant agents which are effective against many clinical and experimental neuropathic pain states. We examined the efficacy of these agents in a new rat model of secondary mechanical hyperalgesia generated by a mild thermal injury. Under brief halothane anesthesia, an injury was induced by applying one heel to a hot surface (52.5°C) for 45 s. GBP, IBG or saline was injected i.p. just prior to the injury. Mean mechanical withdrawal threshold (MWT) was determined using von Frey hairs before and at 30 min intervals for 3 h following the injury. MWT outside the injury area decreased post-injury (secondary hyperalgesia, allodynia), but primary (site of injury) mechanical hyperalgesia was not observed. Secondary hyperalgesia exhibited a tendency toward recovery over time. Time to onset of the anti-allodynic effect of GBP was 30–60 min. The minimum effective GBP dose was 100 mg/kg; 300 mg/kg GBP totally inhibited the drop in MWT, but was accompanied by pronounced sedation. Anti-allodynic effects of IBG were apparent at the first post-injury measure of MWT (30 min). Thirty milligrams per kilogram was the minimum effective dose; 100 mg/kg IBG totally blocked the allodynia with minimal side effects. Our findings demonstrate a dose-dependent blockade of the mechanical sensitivity caused by a mild thermal injury by both GBP and IBG. Results indicate that IBG is more effective than GBP in this model at doses which do not cause sedation. These observations support the suggested use of these or related γ-amino acid analogues as an effective treatment for post-operative pain. |
doi_str_mv | 10.1016/S0006-8993(98)00890-7 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70054003</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006899398008907</els_id><sourcerecordid>17100214</sourcerecordid><originalsourceid>FETCH-LOGICAL-c445t-8daab79502306e0e7ae68773fc89c95433444a19bac043f67b31f488ea0b98493</originalsourceid><addsrcrecordid>eNqFkM1O3DAQgK2Kii7QR0DKASFQ5TKOndg-VRUCWgmphy0HTtbEmVC3-VnsLNI-F-_BMzX7IzhyGo3mm7-PsWMBXwWI8mIOACU31soza84BjAWuP7CZMDrnZa5gj81ekU_sIKW_UyqlhX22b42QeWFn7H6-SiN1wWcPWOGC-jH0GfZ1Nj_7cs4lD2moluOq5S_PHLvQb7I44ehDnVXt4P9lifzQ1xhX2Z_VgiK2D5QCHrGPDbaJPu_iIbu7vvp9-YPf_rr5efn9lnulipGbGrHStoBcQklAGqk0WsvGG-ttoaRUSqGwFXpQsil1JUWjjCGEyhpl5SE73c5dxOFxSWl0XUie2hZ7GpbJaYBCrR9_DxRaAORCTWCxBX0cUorUuEUM3fSfE-DW7t3GvVuLdda4jXunp77j3YJl1VH92rWTPdVPdnVMHtsmYu9DehtemNKYcsK-bTGarD0Fii75QL2nOkTyo6uH8M4h_wE4PaAy</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17100214</pqid></control><display><type>article</type><title>Systemic gabapentin and S(+)-3-isobutyl-γ-aminobutyric acid block secondary hyperalgesia</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Jones, Denise L. ; Sorkin, Linda S.</creator><creatorcontrib>Jones, Denise L. ; Sorkin, Linda S.</creatorcontrib><description>Gabapentin (GBP) and
S(+)-3-isobutyl-γ-aminobutyric acid (IBG) are anticonvulsant agents which are effective against many clinical and experimental neuropathic pain states. We examined the efficacy of these agents in a new rat model of secondary mechanical hyperalgesia generated by a mild thermal injury. Under brief halothane anesthesia, an injury was induced by applying one heel to a hot surface (52.5°C) for 45 s. GBP, IBG or saline was injected i.p. just prior to the injury. Mean mechanical withdrawal threshold (MWT) was determined using von Frey hairs before and at 30 min intervals for 3 h following the injury. MWT outside the injury area decreased post-injury (secondary hyperalgesia, allodynia), but primary (site of injury) mechanical hyperalgesia was not observed. Secondary hyperalgesia exhibited a tendency toward recovery over time. Time to onset of the anti-allodynic effect of GBP was 30–60 min. The minimum effective GBP dose was 100 mg/kg; 300 mg/kg GBP totally inhibited the drop in MWT, but was accompanied by pronounced sedation. Anti-allodynic effects of IBG were apparent at the first post-injury measure of MWT (30 min). Thirty milligrams per kilogram was the minimum effective dose; 100 mg/kg IBG totally blocked the allodynia with minimal side effects. Our findings demonstrate a dose-dependent blockade of the mechanical sensitivity caused by a mild thermal injury by both GBP and IBG. Results indicate that IBG is more effective than GBP in this model at doses which do not cause sedation. These observations support the suggested use of these or related γ-amino acid analogues as an effective treatment for post-operative pain.</description><identifier>ISSN: 0006-8993</identifier><identifier>EISSN: 1872-6240</identifier><identifier>DOI: 10.1016/S0006-8993(98)00890-7</identifier><identifier>PMID: 9813259</identifier><identifier>CODEN: BRREAP</identifier><language>eng</language><publisher>London: Elsevier B.V</publisher><subject>Acetates - administration & dosage ; Acetates - pharmacology ; Allodynia ; Amines ; Animals ; Anticonvulsants - administration & dosage ; Anticonvulsants - pharmacology ; Anticonvulsants. Antiepileptics. Antiparkinson agents ; Biological and medical sciences ; Burns - complications ; Cyclohexanecarboxylic Acids ; Dose-Response Relationship, Drug ; Gabapentin ; gamma-Aminobutyric Acid - administration & dosage ; gamma-Aminobutyric Acid - analogs & derivatives ; gamma-Aminobutyric Acid - pharmacology ; Hyperalgesia - etiology ; Hyperalgesia - prevention & control ; Injections, Intraperitoneal ; Male ; Medical sciences ; Neuropharmacology ; Pain ; Pain modulation ; Pain Threshold - drug effects ; Pharmacology ; Pharmacology. Drug treatments ; Pregabalin ; Rat ; Rats ; Rats, Sprague-Dawley ; Thermal injury</subject><ispartof>Brain research, 1998-11, Vol.810 (1), p.93-99</ispartof><rights>1998 Elsevier Science B.V.</rights><rights>1999 INIST-CNRS</rights><rights>Copyright 1998 Elsevier Science B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c445t-8daab79502306e0e7ae68773fc89c95433444a19bac043f67b31f488ea0b98493</citedby><cites>FETCH-LOGICAL-c445t-8daab79502306e0e7ae68773fc89c95433444a19bac043f67b31f488ea0b98493</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0006-8993(98)00890-7$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1586886$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9813259$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jones, Denise L.</creatorcontrib><creatorcontrib>Sorkin, Linda S.</creatorcontrib><title>Systemic gabapentin and S(+)-3-isobutyl-γ-aminobutyric acid block secondary hyperalgesia</title><title>Brain research</title><addtitle>Brain Res</addtitle><description>Gabapentin (GBP) and
S(+)-3-isobutyl-γ-aminobutyric acid (IBG) are anticonvulsant agents which are effective against many clinical and experimental neuropathic pain states. We examined the efficacy of these agents in a new rat model of secondary mechanical hyperalgesia generated by a mild thermal injury. Under brief halothane anesthesia, an injury was induced by applying one heel to a hot surface (52.5°C) for 45 s. GBP, IBG or saline was injected i.p. just prior to the injury. Mean mechanical withdrawal threshold (MWT) was determined using von Frey hairs before and at 30 min intervals for 3 h following the injury. MWT outside the injury area decreased post-injury (secondary hyperalgesia, allodynia), but primary (site of injury) mechanical hyperalgesia was not observed. Secondary hyperalgesia exhibited a tendency toward recovery over time. Time to onset of the anti-allodynic effect of GBP was 30–60 min. The minimum effective GBP dose was 100 mg/kg; 300 mg/kg GBP totally inhibited the drop in MWT, but was accompanied by pronounced sedation. Anti-allodynic effects of IBG were apparent at the first post-injury measure of MWT (30 min). Thirty milligrams per kilogram was the minimum effective dose; 100 mg/kg IBG totally blocked the allodynia with minimal side effects. Our findings demonstrate a dose-dependent blockade of the mechanical sensitivity caused by a mild thermal injury by both GBP and IBG. Results indicate that IBG is more effective than GBP in this model at doses which do not cause sedation. These observations support the suggested use of these or related γ-amino acid analogues as an effective treatment for post-operative pain.</description><subject>Acetates - administration & dosage</subject><subject>Acetates - pharmacology</subject><subject>Allodynia</subject><subject>Amines</subject><subject>Animals</subject><subject>Anticonvulsants - administration & dosage</subject><subject>Anticonvulsants - pharmacology</subject><subject>Anticonvulsants. Antiepileptics. Antiparkinson agents</subject><subject>Biological and medical sciences</subject><subject>Burns - complications</subject><subject>Cyclohexanecarboxylic Acids</subject><subject>Dose-Response Relationship, Drug</subject><subject>Gabapentin</subject><subject>gamma-Aminobutyric Acid - administration & dosage</subject><subject>gamma-Aminobutyric Acid - analogs & derivatives</subject><subject>gamma-Aminobutyric Acid - pharmacology</subject><subject>Hyperalgesia - etiology</subject><subject>Hyperalgesia - prevention & control</subject><subject>Injections, Intraperitoneal</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Neuropharmacology</subject><subject>Pain</subject><subject>Pain modulation</subject><subject>Pain Threshold - drug effects</subject><subject>Pharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Pregabalin</subject><subject>Rat</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Thermal injury</subject><issn>0006-8993</issn><issn>1872-6240</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkM1O3DAQgK2Kii7QR0DKASFQ5TKOndg-VRUCWgmphy0HTtbEmVC3-VnsLNI-F-_BMzX7IzhyGo3mm7-PsWMBXwWI8mIOACU31soza84BjAWuP7CZMDrnZa5gj81ekU_sIKW_UyqlhX22b42QeWFn7H6-SiN1wWcPWOGC-jH0GfZ1Nj_7cs4lD2moluOq5S_PHLvQb7I44ehDnVXt4P9lifzQ1xhX2Z_VgiK2D5QCHrGPDbaJPu_iIbu7vvp9-YPf_rr5efn9lnulipGbGrHStoBcQklAGqk0WsvGG-ttoaRUSqGwFXpQsil1JUWjjCGEyhpl5SE73c5dxOFxSWl0XUie2hZ7GpbJaYBCrR9_DxRaAORCTWCxBX0cUorUuEUM3fSfE-DW7t3GvVuLdda4jXunp77j3YJl1VH92rWTPdVPdnVMHtsmYu9DehtemNKYcsK-bTGarD0Fii75QL2nOkTyo6uH8M4h_wE4PaAy</recordid><startdate>19981109</startdate><enddate>19981109</enddate><creator>Jones, Denise L.</creator><creator>Sorkin, Linda S.</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>19981109</creationdate><title>Systemic gabapentin and S(+)-3-isobutyl-γ-aminobutyric acid block secondary hyperalgesia</title><author>Jones, Denise L. ; Sorkin, Linda S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c445t-8daab79502306e0e7ae68773fc89c95433444a19bac043f67b31f488ea0b98493</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Acetates - administration & dosage</topic><topic>Acetates - pharmacology</topic><topic>Allodynia</topic><topic>Amines</topic><topic>Animals</topic><topic>Anticonvulsants - administration & dosage</topic><topic>Anticonvulsants - pharmacology</topic><topic>Anticonvulsants. Antiepileptics. Antiparkinson agents</topic><topic>Biological and medical sciences</topic><topic>Burns - complications</topic><topic>Cyclohexanecarboxylic Acids</topic><topic>Dose-Response Relationship, Drug</topic><topic>Gabapentin</topic><topic>gamma-Aminobutyric Acid - administration & dosage</topic><topic>gamma-Aminobutyric Acid - analogs & derivatives</topic><topic>gamma-Aminobutyric Acid - pharmacology</topic><topic>Hyperalgesia - etiology</topic><topic>Hyperalgesia - prevention & control</topic><topic>Injections, Intraperitoneal</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Neuropharmacology</topic><topic>Pain</topic><topic>Pain modulation</topic><topic>Pain Threshold - drug effects</topic><topic>Pharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Pregabalin</topic><topic>Rat</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Thermal injury</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jones, Denise L.</creatorcontrib><creatorcontrib>Sorkin, Linda S.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Brain research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jones, Denise L.</au><au>Sorkin, Linda S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Systemic gabapentin and S(+)-3-isobutyl-γ-aminobutyric acid block secondary hyperalgesia</atitle><jtitle>Brain research</jtitle><addtitle>Brain Res</addtitle><date>1998-11-09</date><risdate>1998</risdate><volume>810</volume><issue>1</issue><spage>93</spage><epage>99</epage><pages>93-99</pages><issn>0006-8993</issn><eissn>1872-6240</eissn><coden>BRREAP</coden><abstract>Gabapentin (GBP) and
S(+)-3-isobutyl-γ-aminobutyric acid (IBG) are anticonvulsant agents which are effective against many clinical and experimental neuropathic pain states. We examined the efficacy of these agents in a new rat model of secondary mechanical hyperalgesia generated by a mild thermal injury. Under brief halothane anesthesia, an injury was induced by applying one heel to a hot surface (52.5°C) for 45 s. GBP, IBG or saline was injected i.p. just prior to the injury. Mean mechanical withdrawal threshold (MWT) was determined using von Frey hairs before and at 30 min intervals for 3 h following the injury. MWT outside the injury area decreased post-injury (secondary hyperalgesia, allodynia), but primary (site of injury) mechanical hyperalgesia was not observed. Secondary hyperalgesia exhibited a tendency toward recovery over time. Time to onset of the anti-allodynic effect of GBP was 30–60 min. The minimum effective GBP dose was 100 mg/kg; 300 mg/kg GBP totally inhibited the drop in MWT, but was accompanied by pronounced sedation. Anti-allodynic effects of IBG were apparent at the first post-injury measure of MWT (30 min). Thirty milligrams per kilogram was the minimum effective dose; 100 mg/kg IBG totally blocked the allodynia with minimal side effects. Our findings demonstrate a dose-dependent blockade of the mechanical sensitivity caused by a mild thermal injury by both GBP and IBG. Results indicate that IBG is more effective than GBP in this model at doses which do not cause sedation. These observations support the suggested use of these or related γ-amino acid analogues as an effective treatment for post-operative pain.</abstract><cop>London</cop><cop>Amsterdam</cop><cop>New York, NY</cop><pub>Elsevier B.V</pub><pmid>9813259</pmid><doi>10.1016/S0006-8993(98)00890-7</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0006-8993 |
ispartof | Brain research, 1998-11, Vol.810 (1), p.93-99 |
issn | 0006-8993 1872-6240 |
language | eng |
recordid | cdi_proquest_miscellaneous_70054003 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Acetates - administration & dosage Acetates - pharmacology Allodynia Amines Animals Anticonvulsants - administration & dosage Anticonvulsants - pharmacology Anticonvulsants. Antiepileptics. Antiparkinson agents Biological and medical sciences Burns - complications Cyclohexanecarboxylic Acids Dose-Response Relationship, Drug Gabapentin gamma-Aminobutyric Acid - administration & dosage gamma-Aminobutyric Acid - analogs & derivatives gamma-Aminobutyric Acid - pharmacology Hyperalgesia - etiology Hyperalgesia - prevention & control Injections, Intraperitoneal Male Medical sciences Neuropharmacology Pain Pain modulation Pain Threshold - drug effects Pharmacology Pharmacology. Drug treatments Pregabalin Rat Rats Rats, Sprague-Dawley Thermal injury |
title | Systemic gabapentin and S(+)-3-isobutyl-γ-aminobutyric acid block secondary hyperalgesia |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T10%3A47%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Systemic%20gabapentin%20and%20S(+)-3-isobutyl-%CE%B3-aminobutyric%20acid%20block%20secondary%20hyperalgesia&rft.jtitle=Brain%20research&rft.au=Jones,%20Denise%20L.&rft.date=1998-11-09&rft.volume=810&rft.issue=1&rft.spage=93&rft.epage=99&rft.pages=93-99&rft.issn=0006-8993&rft.eissn=1872-6240&rft.coden=BRREAP&rft_id=info:doi/10.1016/S0006-8993(98)00890-7&rft_dat=%3Cproquest_cross%3E17100214%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17100214&rft_id=info:pmid/9813259&rft_els_id=S0006899398008907&rfr_iscdi=true |